Erytrust 2000Iu/0.5Ml Inj belongs to a class of drugs known as erythropoiesis-stimulating agent (ESA) primarily used to treat anaemia (lack of haemoglobin in blood) due to chronic kidney disease and anaemia due to chemotherapy (cancer treatment). Anaemia is reduced levels of haemoglobin and red blood cells (RBCs) in the blood. Chronic kidney disease (CKD) patients slowly develop anaemia, which gets worse as the disease progresses. Also, the treatment of cancer, including chemotherapy and radiotherapy, causes anaemia in cancer patients.
Erytrust 2000Iu/0.5Ml Inj contains ‘Erythropoietin alfa, human recombinant’. Erytrust 2000Iu/0.5Ml Inj works by stimulating the bone marrow (soft tissue within the bones that makes red blood cells) to make more red blood cells. This Erytrust 2000Iu/0.5Ml Inj is very similar to the natural substance in the body known as erythropoietin (hormone formed by kidneys and produced RBC), preventing anaemia (lack of haemoglobin and RBC in the blood).
Erytrust 2000Iu/0.5Ml Inj will be administered by a healthcare professional; do not self-administer. You may experience high blood pressure, nausea, vomiting and fever. Most of these side effects of Erytrust 2000Iu/0.5Ml Inj do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are known to be allergic to Erytrust 2000Iu/0.5Ml Inj or any other medicines, please tell your doctor. Erytrust 2000Iu/0.5Ml Inj should not be taken in conditions like heart disease, high blood pressure, or liver disease. If you are pregnant or a nursing mother, it is advised to consult a doctor before using Erytrust 2000Iu/0.5Ml Inj. Erytrust 2000Iu/0.5Ml Inj may affect your ability to drive and use machines as Erytrust 2000Iu/0.5Ml Inj may cause fits disorder during the first 90 days of treatment.